Search Results - "Snijders, Marc PLM"

Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study by Reijnen, Casper, Visser, Nicole Cm, Kasius, Jenneke C, Boll, Dorry, Geomini, Peggy M, Ngo, Huy, Van Hamont, Dennis, Pijlman, Brenda M, Vos, Maria Caroline, Bulten, Johan, Snijders, Marc Plm, Massuger, Leon Fag, Pijnenborg, Johanna Ma

“…The global obesity epidemic has great impact on the prevalence of low-grade endometrial carcinoma. The preoperative tumor serum marker cancer antigen 125…”
Get full text

L1CAM expression in endometrial carcinomas: an ENITEC collaboration study by van der Putten, Louis JM, Visser, Nicole CM, van de Vijver, Koen, Santacana, Maria, Bronsert, Peter, Bulten, Johan, Hirschfeld, Marc, Colas, Eva, Gil-Moreno, Antonio, Garcia, Angel, Mancebo, Gemma, Alameda, Fransesc, Trovik, Jone, Kopperud, Reidun K, Huvila, Jutta, Schrauwen, Stefanie, Koskas, Martin, Walker, Francine, Weinberger, Vit, Minar, Lubos, Jandakova, Eva, Snijders, Marc PLM, van den Berg-van Erp, Saskia, Matias-Guiu, Xavier, Salvesen, Helga B, Amant, Frederic, Massuger, Leon FAG, Pijnenborg, Johanna MA

Get full text

L1CAM expression in endometrial carcinomas: an ENITEC collaboration study by van der Putten, Louis JM, Visser, Nicole CM, van de Vijver, Koen, Santacana, Maria, Bronsert, Peter, Bulten, Johan, Hirschfeld, Marc, Colas, Eva, Gil-Moreno, Antonio, Garcia, Angel, Mancebo, Gemma, Alameda, Fransesc, Trovik, Jone, Kopperud, Reidun K, Huvila, Jutta, Schrauwen, Stefanie, Koskas, Martin, Walker, Francine, Weinberger, Vit, Minar, Lubos, Jandakova, Eva, Snijders, Marc PLM, van den Berg-van Erp, Saskia, Matias-Guiu, Xavier, Salvesen, Helga B, Amant, Frederic, Massuger, Leon FAG, Pijnenborg, Johanna MA

“…Background: Identification of aggressive endometrioid endometrial carcinomas (EECs) and non-endometrioid carcinomas (NEECs) is essential to improve outcome. L1…”
Get full text

The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study by van Weelden, Willem Jan, Reijnen, Casper, Küsters-Vandevelde, Heidi V.N., Bulten, Johan, Bult, Peter, Leung, Samuel, Visser, Nicole C.M., Santacana, Maria, Bronsert, Peter, Hirschfeld, Marc, Colas, Eva, Gil-Moreno, Antonio, Reques, Armando, Mancebo, Gemma, Huvila, Jutta, Koskas, Martin, Weinberger, Vit, Bednarikova, Marketa, Hausnerova, Jitka, Snijders, Marc P.L.M., Matias-Guiu, Xavier, Amant, Frédéric, Krakstad, Camilla, van de Vijver, Koen, McAlpine, Jessica, Pijnenborg, Johanna M.A.

“…There is no consensus on the cutoff for positivity of estrogen receptor (ER) and progesterone receptor (PR) in endometrial cancer (EC). Therefore, we…”
Get full text

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome by Reijnen, Casper, Küsters‐Vandevelde, Heidi V.N., Ligtenberg, Marjolijn J.L., Bulten, Johan, Oosterwegel, Marloes, Snijders, Marc P.L.M., Sweegers, Sanne, Hullu, Joanne A., Vos, Maria C., Wurff, Anneke A.M., Altena, Anne M., Eijkelenboom, Astrid, Pijnenborg, Johanna M.A.

“…Synchronous primary endometrial and ovarian cancers (SEOs) represent 10% of all endometrial and ovarian cancers and are assumed to develop as independent…”
Get full text

Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study by Reijnen, Casper, Putten, Louis J.M., Bulten, Johan, Snijders, Marc P.L.M., Küsters‐Vandevelde, Heidi V.N., Sweegers, Sanne, Vos, Maria C., Wurff, Anneke A.M., Ligtenberg, Marjolijn J.L., Massuger, Leon F.A.G., Eijkelenboom, Astrid, Pijnenborg, Johanna M.A.

“…Endometrial carcinoma (EC) is traditionally diagnosed by a histopathological assessment of an endometrial biopsy, leaving up to 30% of patients undiagnosed due…”
Get full text

Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study by van der Putten, Louis J M, Visser, Nicole C M, van de Vijver, Koen, Santacana, Maria, Bronsert, Peter, Bulten, Johan, Hirschfeld, Marc, Colas, Eva, Gil-Moreno, Antonio, Garcia, Angel, Mancebo, Gemma, Alameda, Fransesc, Trovik, Jone, Kopperud, Reidun K, Huvila, Jutta, Schrauwen, Stefanie, Koskas, Martin, Walker, Francine, Weinberger, Vit, Minar, Lubos, Jandakova, Eva, Snijders, Marc P L M, van den Berg-van Erp, Saskia, Matias-Guiu, Xavier, Salvesen, Helga B, Werner, Henrica M J, Amant, Frederic, Massuger, Leon F A G, Pijnenborg, Johanna M A

“…Endometrial carcinoma mortality is mainly caused by recurrent disease, and various immunohistochemical markers to predict recurrences have been studied. Loss…”
Get more information

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer by van Bommel, Majke H D, Pijnenborg, Johanna M A, van der Putten, Louis J M, Bulten, Johan, Snijders, Marc P L M, Küsters-Vandevelde, Heidi V N, Sweegers, Sanne, Vos, M Caroline, Ligtenberg, Marjolein J L, Eijkelenboom, Astrid, de Hullu, Joanne A, Reijnen, Casper

“…Ovarian cancer is known for its poor prognosis, which is mainly due to the lack of early symptoms and adequate screening options. In this study we evaluated…”
Get more information

Abstract 4879: Poor outcome in hypoxic endometrial carcinoma is related to vascular density by Reijnen, Casper, Weelden, Willem Jan van, Arts, Martijn SJP, Peters, Johan P., Rijken, Paul F., Vijver, Koen van de, Santacana, Maria, Bronsert, Peter, Bulten, Johan, Hirschfeld, Marc, Colas, Eva, Gil-Moreno, Antonio, Reques, Amando, Mancebo, Gemma, Alameda, Fransesc, Krakstad, Camilla, Trovik, Jone, Haldorsen, Ingfrid S., Huvila, Jutta, Schrouwen, Stefanie, Koskas, Martin, Walker, Francine, Weinberger, Vit, Minar, Lubos, Jandakova, Eva, Snijders, Marc PLM, Erp, Saskia van den Berg-van, Küsters-Vandevelde, Heidi VN, Matias-Guiu, Xavier, Amant, Frederic, Massuger, Leon FAG, Bussink, Johan, Pijnenborg, Johanna MA

“…Abstract Optimal identification of endometrial carcinoma (EC) patients at high risk of recurrence is currently lacking. Hypoxia is an important feature of…”
Get full text

Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study by Visser, Nicole C.M., van der Putten, Louis J.M., van Egerschot, Alex, Van de Vijver, Koen K., Santacana, Maria, Bronsert, Peter, Hirschfeld, Marc, Colas, Eva, Gil-Moreno, Antonio, Garcia, Angel, Mancebo, Gemma, Alameda, Francesc, Krakstad, Camilla, Tangen, Ingvild L., Huvila, Jutta, Schrauwen, Stefanie, Koskas, Martin, Walker, Francine, Weinberger, Vit, Minar, Lubos, Hausnerova, Jitka, Snijders, Marc P.L.M., van den Berg-van Erp, Saskia, Matias-Guiu, Xavier, Trovik, Jone, Amant, Frédéric, Massuger, Leon F.A.G., Bulten, Johan, Pijnenborg, Johanna M.A.

“…Discrimination between low- and high-grade endometrial carcinomas (ECs) is clinically relevant but can be challenging for pathologists, with moderate…”
Get full text

Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma by Reijnen, Casper, Küsters-Vandevelde, Heidi V.N., Abbink, Karin, Zusterzeel, Petra L.M., van Herwaarden, Antonius E., van der Laak, Jeroen A.W.M., Massuger, Leon F.A.G., Snijders, Marc P.L.M., Pijnenborg, Johanna M.A., Bulten, Johan

“…Endometrioid endometrial carcinomas (EECs) are correlated with high serum levels of androgens and estrogen. We hypothesized that Leydig cells and ovarian…”
Get full text